RxDoctor Payments Data

Abraham Scheer, MD

Neurology · Dover, DENPI 1124195417

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $215,689 of the $230,940 with a category attached, or 93.4%. Milestone Scientific Inc. accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $145,112 and has fallen 97.9% since, to $2,994 in 2023. Among neurology clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$230,940in general payments, 2019–2025

Across 29 payments — averaging $7963.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Milestone Scientific Inc.$231K
  • Portola Pharmaceuticals, LLC$15
$254,629in ownership & investment interests, 2019–2025

Across 7 payments — averaging $36,376 each. An ownership or investment interest held by the physician or an immediate family member.

  • Milestone Scientific Inc.$255K

What the payments were for

  • Consulting fees$7,1503%
  • Speaking & faculty fees$2,9941%
  • Travel & lodging$1,9781%
  • Food & beverage$150%
  • Education$3,1151%
  • Ownership interest$215,68993%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$230,940 in reported general payments places this provider in the 95th percentile of 61 neurology providers in Delaware.

See all neurology providers in Delaware

Medicare billing

Part B allowed, 2024
$17,213
Medicare patients
130
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Dover

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →